Otonkoski T - Search Results

1

Severe persistent hyperinsulinemic hypoglycemia due to a de novo glucokinase mutation.

Cuesta-Muñoz AL, Huopio H, Otonkoski T, Gomez-Zumaquero JM, Näntö-Salonen K, Rahier J, López-Enriquez S, García-Gimeno MA, Sanz P, Soriguer FC, Laakso M. Cuesta-Muñoz AL, et al. Among authors: otonkoski t. Diabetes. 2004 Aug;53(8):2164-8. doi: 10.2337/diabetes.53.8.2164. Diabetes. 2004. PMID: 15277402

2

Clinical heterogeneity in monogenic diabetes caused by mutations in the glucokinase gene (GCK-MODY).

Cuesta-Muñoz AL, Tuomi T, Cobo-Vuilleumier N, Koskela H, Odili S, Stride A, Buettger C, Otonkoski T, Froguel P, Grimsby J, Garcia-Gimeno M, Matschinsky FM. Cuesta-Muñoz AL, et al. Among authors: otonkoski t. Diabetes Care. 2010 Feb;33(2):290-2. doi: 10.2337/dc09-0681. Epub 2009 Nov 10. Diabetes Care. 2010. PMID: 19903754 Free PMC article.

3

Noninvasive diagnosis of focal hyperinsulinism of infancy with [18F]-DOPA positron emission tomography.

Otonkoski T, Näntö-Salonen K, Seppänen M, Veijola R, Huopio H, Hussain K, Tapanainen P, Eskola O, Parkkola R, Ekström K, Guiot Y, Rahier J, Laakso M, Rintala R, Nuutila P, Minn H. Otonkoski T, et al. Diabetes. 2006 Jan;55(1):13-8. Diabetes. 2006. PMID: 16380471

4

Carriers of an inactivating beta-cell ATP-sensitive K(+) channel mutation have normal glucose tolerance and insulin sensitivity and appropriate insulin secretion.

Huopio H, Vauhkonen I, Komulainen J, Niskanen L, Otonkoski T, Laakso M. Huopio H, et al. Among authors: otonkoski t. Diabetes Care. 2002 Jan;25(1):101-6. doi: 10.2337/diacare.25.1.101. Diabetes Care. 2002. PMID: 11772909

5

A point mutation inactivating the sulfonylurea receptor causes the severe form of persistent hyperinsulinemic hypoglycemia of infancy in Finland.

Otonkoski T, Ammälä C, Huopio H, Cote GJ, Chapman J, Cosgrove K, Ashfield R, Huang E, Komulainen J, Ashcroft FM, Dunne MJ, Kere J, Thomas PM. Otonkoski T, et al. Diabetes. 1999 Feb;48(2):408-15. doi: 10.2337/diabetes.48.2.408. Diabetes. 1999. PMID: 10334322

6

A mouse model of human hyperinsulinism produced by the E1506K mutation in the sulphonylurea receptor SUR1.

Shimomura K, Tusa M, Iberl M, Brereton MF, Kaizik S, Proks P, Lahmann C, Yaluri N, Modi S, Huopio H, Ustinov J, Otonkoski T, Laakso M, Ashcroft FM. Shimomura K, et al. Among authors: otonkoski t. Diabetes. 2013 Nov;62(11):3797-806. doi: 10.2337/db12-1611. Epub 2013 Jul 31. Diabetes. 2013. PMID: 23903354 Free PMC article.

7

A new subtype of autosomal dominant diabetes attributable to a mutation in the gene for sulfonylurea receptor 1.

Huopio H, Otonkoski T, Vauhkonen I, Reimann F, Ashcroft FM, Laakso M. Huopio H, et al. Among authors: otonkoski t. Lancet. 2003 Jan 25;361(9354):301-7. doi: 10.1016/S0140-6736(03)12325-2. Lancet. 2003. PMID: 12559865

8

[Congenital hyperinsulinism].

Huopio H, Laakso M, Otonkoski T. Huopio H, et al. Among authors: otonkoski t. Duodecim. 2005;121(11):1166-75. Duodecim. 2005. PMID: 15999971 Review. Finnish. No abstract available.

9

Dominantly inherited hyperinsulinism caused by a mutation in the sulfonylurea receptor type 1.

Huopio H, Reimann F, Ashfield R, Komulainen J, Lenko HL, Rahier J, Vauhkonen I, Kere J, Laakso M, Ashcroft F, Otonkoski T. Huopio H, et al. Among authors: otonkoski t. J Clin Invest. 2000 Oct;106(7):897-906. doi: 10.1172/JCI9804. J Clin Invest. 2000. PMID: 11018078 Free PMC article.

10

[Neonatal diabetes mellitus].

Huopio H, Otonkoski T. Huopio H, et al. Among authors: otonkoski t. Duodecim. 2011;127(6):534-41. Duodecim. 2011. PMID: 21528518 Review. Finnish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

220 results

Search Page

Filters